Pregnancy and Childbirth
Conditions
Interventions
Paracetamol
Sponsors
Olufunke Oso
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Parturients, Aged 18–35 years, Spontaneous onset of labour at term (37–41 weeks + 6 days gestation), Cervical dilatation of 6-7 cm A single live fetus in cephalic presentation Consent to participate in the study
Exclusion criteria
Exclusion criteria: Multiple pregnancy Previous uterine scar Cervical dilation = 5 and = 8cm at admission Chronic or pregnancy-induced medical conditions Presence of any contraindication to vaginal delivery Fetal distress Congenital malformations Intrauterine growth restriction Intrauterine fetal death Allergy to paracetamol Breech Presentation Use of any other kind of analgesia before recruitment to the study Non-consenting patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome was the efficacy of the drug to provide adequate analgesia by the change in the visual analog scale pain intensity score after administration of the drug. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome was the incidence of side effects and neonatal APGAR scores at one and five minutes of birth | — |
Countries
Nigeria
Contacts
Public ContactOlusola Aduloju
Consultant at the Ekiti State Teaching Hospital Ado Ekiti
Outcome results
None listed